H Blair Simpson, MD, PhD - Publications

Affiliations: 
Psychiatry Columbia University, New York, NY 
Area:
Psychiatry, OCD

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wheaton MG, Galfalvy H, Steinman SA, Wall MM, Foa EB, Simpson HB. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well? Behaviour Research and Therapy. 85: 6-12. PMID 27497840 DOI: 10.1016/j.brat.2016.07.010  1
2016 Godier LR, de Wit S, Pinto A, Steinglass JE, Greene AL, Scaife J, Gillan CM, Walsh BT, Simpson HB, Park RJ. An investigation of habit learning in Anorexia Nervosa. Psychiatry Research. 244: 214-222. PMID 27497292 DOI: 10.1016/j.psychres.2016.07.051  1
2016 Cha J, Ide JS, Bowman FD, Simpson HB, Posner J, Steinglass JE. Abnormal reward circuitry in anorexia nervosa: A longitudinal, multimodal MRI study. Human Brain Mapping. PMID 27273474 DOI: 10.1002/hbm.23279  1
2016 Glasofer DR, Albano AM, Simpson HB, Steinglass JE. Overcoming fear of eating: A case study of a novel use of exposure and response prevention. Psychotherapy (Chicago, Ill.). 53: 223-231. PMID 27267508 DOI: 10.1037/pst0000048  0.4
2016 Schneier FR, Kimeldorf MB, Choo TH, Steinglass JE, Wall MM, Fyer AJ, Simpson HB. Attention bias in adults with anorexia nervosa, obsessive-compulsive disorder, and social anxiety disorder. Journal of Psychiatric Research. 79: 61-69. PMID 27174402 DOI: 10.1016/j.jpsychires.2016.04.009  1
2016 Rodriguez CI, Wheaton M, Zwerling J, Steinman SA, Sonnenfeld D, Galfalvy H, Simpson HB. Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial. The Journal of Clinical Psychiatry. 77: 408-409. PMID 27046314 DOI: 10.4088/JCP.15l10138  1
2016 Steinman SA, Ahmari SE, Choo T, Kimeldorf MB, Feit R, Loh S, Risbrough V, Geyer MA, Steinglass JE, Wall M, Schneier FR, Fyer AJ, Simpson HB. PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER. Depression and Anxiety. 33: 238-46. PMID 26878422 DOI: 10.1002/da.22474  0.4
2016 Cha J, Greenberg T, Song I, Simpson HB, Posner J, Mujica-Parodi LR. Abnormal hippocampal structure and function in clinical anxiety and comorbid depression. Hippocampus. PMID 26743454 DOI: 10.1002/hipo.22566  0.68
2015 McLean CP, Zandberg LJ, Van Meter PE, Carpenter JK, Simpson HB, Foa EB. Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies. The Journal of Clinical Psychiatry. PMID 26613263 DOI: 10.4088/JCP.14m09513  1
2015 Leonard RC, Franklin ME, Wetterneck CT, Riemann BC, Simpson HB, Kinnear K, Cahill SP, Lake PM. Residential treatment outcomes for adolescents with obsessive-compulsive disorder. Psychotherapy Research : Journal of the Society For Psychotherapy Research. 1-10. PMID 26308588 DOI: 10.1080/10503307.2015.1065022  1
2015 Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, Vermes D, Xie S, Hunter L, Flood P, Moore H, Shungu DC, Simpson HB. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. Psychiatry Research. PMID 26104826 DOI: 10.1016/j.pscychresns.2015.06.001  1
2015 Zandberg LJ, Zang Y, McLean CP, Yeh R, Simpson HB, Foa EB. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention. Behaviour Research and Therapy. 68: 76-81. PMID 25824533 DOI: 10.1016/j.brat.2015.03.005  1
2015 Simpson HB, Kegeles LS, Hunter L, Mao X, Van Meter P, Xu X, Kimeldorf MB, Pearlstein SL, Slifstein M, Shungu DC. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy. Psychiatry Research. 232: 65-70. PMID 25715904 DOI: 10.1016/j.pscychresns.2015.01.009  1
2015 Fineberg NA, Reghunandanan S, Simpson HB, Phillips KA, Richter MA, Matthews K, Stein DJ, Sareen J, Brown A, Sookman D. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults. Psychiatry Research. 227: 114-25. PMID 25681005 DOI: 10.1016/j.psychres.2014.12.003  1
2015 Pinto A, Greene AL, Storch EA, Simpson HB. Prevalence of Childhood Obsessive-Compulsive Personality Traits in Adults with Obsessive Compulsive Disorder versus Obsessive Compulsive Personality Disorder. Journal of Obsessive-Compulsive and Related Disorders. 4: 25-29. PMID 25574456 DOI: 10.1016/j.jocrd.2014.11.002  1
2015 Foa EB, Simpson HB, Rosenfield D, Liebowitz MR, Cahill SP, Huppert JD, Bender J, McLean CP, Maher MJ, Campeas R, Hahn CG, Imms P, Pinto A, Powers MB, Rodriguez CI, et al. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 76: 440-6. PMID 25375780 DOI: 10.4088/JCP.14m09044  1
2015 Cain NM, Ansell EB, Simpson HB, Pinto A. Interpersonal functioning in obsessive-compulsive personality disorder. Journal of Personality Assessment. 97: 90-9. PMID 25046040 DOI: 10.1080/00223891.2014.934376  1
2014 Simpson HB, Reddy YC. Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 36: 3-13. PMID 25388607 DOI: 10.1590/1516-4446-2013-1229  1
2014 Shavitt RG, de Mathis MA, Oki F, Ferrao YA, Fontenelle LF, Torres AR, Diniz JB, Costa DL, do Rosário MC, Hoexter MQ, Miguel EC, Simpson HB. Phenomenology of OCD: lessons from a large multicenter study and implications for ICD-11. Journal of Psychiatric Research. 57: 141-8. PMID 25012187 DOI: 10.1016/j.jpsychires.2014.06.010  1
2014 Williams MT, Farris SG, Turkheimer EN, Franklin ME, Simpson HB, Liebowitz M, Foa EB. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. Journal of Anxiety Disorders. 28: 553-8. PMID 24983796 DOI: 10.1016/j.janxdis.2014.06.001  1
2014 Grant JE, Atmaca M, Fineberg NA, Fontenelle LF, Matsunaga H, Janardhan Reddy YC, Simpson HB, Thomsen PH, van den Heuvel OA, Veale D, Woods DW, Stein DJ. Impulse control disorders and "behavioural addictions" in the ICD-11. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 125-7. PMID 24890056 DOI: 10.1002/wps.20115  1
2014 Patel SR, Humensky JL, Olfson M, Simpson HB, Myers R, Dixon LB. Treatment of obsessive-compulsive disorder in a nationwide survey of office-based physician practice. Psychiatric Services (Washington, D.C.). 65: 681-4. PMID 24585056 DOI: 10.1176/appi.ps.201300192  1
2014 Steinglass JE, Albano AM, Simpson HB, Wang Y, Zou J, Attia E, Walsh BT. Confronting fear using exposure and response prevention for anorexia nervosa: A randomized controlled pilot study. The International Journal of Eating Disorders. 47: 174-80. PMID 24488838 DOI: 10.1002/eat.22214  1
2014 Pinto A, Steinglass JE, Greene AL, Weber EU, Simpson HB. Capacity to delay reward differentiates obsessive-compulsive disorder and obsessive-compulsive personality disorder. Biological Psychiatry. 75: 653-9. PMID 24199665 DOI: 10.1016/j.biopsych.2013.09.007  1
2014 Posner J, Marsh R, Maia TV, Peterson BS, Gruber A, Simpson HB. Reduced functional connectivity within the limbic cortico-striato-thalamo-cortical loop in unmedicated adults with obsessive-compulsive disorder. Human Brain Mapping. 35: 2852-60. PMID 24123377 DOI: 10.1002/hbm.22371  1
2014 Phillips KA, Hart AS, Simpson HB, Stein DJ. Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5. Cns Spectrums. 19: 10-20. PMID 23659348 DOI: 10.1017/S1092852913000266  1
2014 Marsh R, Horga G, Parashar N, Wang Z, Peterson BS, Simpson HB. Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder. Biological Psychiatry. 75: 615-22. PMID 23489416 DOI: 10.1016/j.biopsych.2013.02.004  1
2013 Mantovani A, Rossi S, Bassi BD, Simpson HB, Fallon BA, Lisanby SH. Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. Psychiatry Research. 210: 1026-32. PMID 24064461 DOI: 10.1016/j.psychres.2013.08.054  1
2013 Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, et al. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. Jama Psychiatry. 70: 1190-9. PMID 24026523 DOI: 10.1001/jamapsychiatry.2013.1932  1
2013 Rodriguez CI, Simpson HB, Liu SM, Levinson A, Blanco C. Prevalence and correlates of difficulty discarding: results from a national sample of the US population. The Journal of Nervous and Mental Disease. 201: 795-801. PMID 23995036 DOI: 10.1097/NMD.0b013e3182a21471  1
2013 Farris SG, McLean CP, Van Meter PE, Simpson HB, Foa EB. Treatment response, symptom remission, and wellness in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 74: 685-90. PMID 23945445 DOI: 10.4088/JCP.12m07789  1
2013 Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2475-83. PMID 23783065 DOI: 10.1038/npp.2013.150  1
2013 Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 74: 464-9. PMID 23759449 DOI: 10.4088/JCP.12m08017  1
2013 Rodriguez CI, Bender J, Morrison S, Mehendru R, Tolin D, Simpson HB. Does extended release methylphenidate help adults with hoarding disorder?: a case series. Journal of Clinical Psychopharmacology. 33: 444-7. PMID 23609401 DOI: 10.1097/JCP.0b013e318290115e  1
2013 Rodriguez CI, Arbuckle MR, Simpson HB, Herman DB, Stroup TS, Skrobala AM, Sederer LI, Appel A, Essock SM. Public-academic partnerships: a rapid small-grant program for policy-relevant research: motivating public-academic partnerships. Psychiatric Services (Washington, D.C.). 64: 106-8. PMID 23370621 DOI: 10.1176/appi.ps.201200519  1
2013 Simpson HB, Wetterneck CT, Cahill SP, Steinglass JE, Franklin ME, Leonard RC, Weltzin TE, Riemann BC. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders. Cognitive Behaviour Therapy. 42: 64-76. PMID 23316878 DOI: 10.1080/16506073.2012.751124  1
2013 LeBeau RT, Mischel ER, Simpson HB, Mataix-Cols D, Phillips KA, Stein DJ, Craske MG. Preliminary assessment of obsessive-compulsive spectrum disorder scales for DSM-5 Journal of Obsessive-Compulsive and Related Disorders. 2: 114-118. DOI: 10.1016/j.jocrd.2013.01.005  1
2012 Simpson HB, Marcus SM, Zuckoff A, Franklin M, Foa EB. Patient adherence to cognitive-behavioral therapy predicts long-term outcome in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 73: 1265-6. PMID 23059155 DOI: 10.4088/JCP.12l07879  1
2012 Simpson HB, Shungu DC, Bender J, Mao X, Xu X, Slifstein M, Kegeles LS. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2684-92. PMID 22850733 DOI: 10.1038/npp.2012.132  1
2012 Steinglass JE, Figner B, Berkowitz S, Simpson HB, Weber EU, Walsh BT. Increased capacity to delay reward in anorexia nervosa. Journal of the International Neuropsychological Society : Jins. 18: 773-80. PMID 22591835 DOI: 10.1017/S1355617712000446  1
2012 Stein DJ, Koen N, Fineberg N, Fontenelle LF, Matsunaga H, Osser D, Simpson HB. A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Current Psychiatry Reports. 14: 211-9. PMID 22527872 DOI: 10.1007/s11920-012-0268-9  1
2012 Simpson HB. The RDoC project: a new paradigm for investigating the pathophysiology of anxiety. Depression and Anxiety. 29: 251-2. PMID 22511360 DOI: 10.1002/da.21935  1
2012 Maher MJ, Wang Y, Zuckoff A, Wall MM, Franklin M, Foa EB, Simpson HB. Predictors of patient adherence to cognitive-behavioral therapy for obsessive-compulsive disorder. Psychotherapy and Psychosomatics. 81: 124-6. PMID 22301680 DOI: 10.1159/000330214  1
2012 Rodriguez CI, Herman D, Alcon J, Chen S, Tannen A, Essock S, Simpson HB. Prevalence of hoarding disorder in individuals at potential risk of eviction in New York City: a pilot study. The Journal of Nervous and Mental Disease. 200: 91-4. PMID 22210369 DOI: 10.1097/NMD.0b013e31823f678b  1
2012 Steinglass J, Albano AM, Simpson HB, Carpenter K, Schebendach J, Attia E. Fear of food as a treatment target: exposure and response prevention for anorexia nervosa in an open series. The International Journal of Eating Disorders. 45: 615-21. PMID 21541979 DOI: 10.1002/eat.20936  1
2011 Simpson HB, Zuckoff A. Using Motivational Interviewing to Enhance Treatment Outcome in People With Obsessive-Compulsive Disorder. Cognitive and Behavioral Practice. 18: 28-37. PMID 24707163 DOI: 10.1016/j.cbpra.2009.06.009  1
2011 Simpson HB, Slifstein M, Bender J, Xu X, Hackett E, Maher MJ, Abi-Dargham A. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Biological Psychiatry. 70: 897-904. PMID 21855857 DOI: 10.1016/j.biopsych.2011.06.023  1
2011 Pinto A, Liebowitz MR, Foa EB, Simpson HB. Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder. Behaviour Research and Therapy. 49: 453-8. PMID 21600563 DOI: 10.1016/j.brat.2011.04.004  1
2011 Rodriguez CI, Kegeles LS, Flood P, Simpson HB. Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 72: 567-9. PMID 21527129 DOI: 10.4088/JCP.10l06653  1
2011 Williams MT, Farris SG, Turkheimer E, Pinto A, Ozanick K, Franklin ME, Liebowitz M, Simpson HB, Foa EB. Myth of the pure obsessional type in obsessive--compulsive disorder. Depression and Anxiety. 28: 495-500. PMID 21509914 DOI: 10.1002/da.20820  1
2011 Simpson HB, Maher MJ, Wang Y, Bao Y, Foa EB, Franklin M. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology. 79: 247-52. PMID 21355639 DOI: 10.1037/a0022659  1
2011 Steinglass JE, Sysko R, Glasofer D, Albano AM, Simpson HB, Walsh BT. Rationale for the application of exposure and response prevention to the treatment of anorexia nervosa. The International Journal of Eating Disorders. 44: 134-41. PMID 20127936 DOI: 10.1002/eat.20784  1
2010 Simpson HB. Pharmacological treatment of obsessive-compulsive disorder. Current Topics in Behavioral Neurosciences. 2: 527-43. PMID 21309125 DOI: 10.1007/7854_2009_12  1
2010 Patel SR, Simpson HB. Patient preferences for obsessive-compulsive disorder treatment. The Journal of Clinical Psychiatry. 71: 1434-9. PMID 21114948 DOI: 10.4088/JCP.09m05537blu  1
2010 Rodriguez CI, Bender J, Marcus SM, Snape M, Rynn M, Simpson HB. Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial. The Journal of Clinical Psychiatry. 71: 1247-9. PMID 20923629 DOI: 10.4088/JCP.09l05805blu  1
2010 Simpson HB, Zuckoff AM, Maher MJ, Page JR, Franklin ME, Foa EB, Schmidt AB, Wang Y. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder. Behaviour Research and Therapy. 48: 941-8. PMID 20609435 DOI: 10.1016/j.brat.2010.05.026  1
2010 Rodriguez CI, Corcoran C, Simpson HB. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms. The American Journal of Psychiatry. 167: 754-61. PMID 20595428 DOI: 10.1176/appi.ajp.2009.09070997  1
2010 Steinglass JE, Sysko R, Mayer L, Berner LA, Schebendach J, Wang Y, Chen H, Albano AM, Simpson HB, Walsh BT. Pre-meal anxiety and food intake in anorexia nervosa. Appetite. 55: 214-8. PMID 20570701 DOI: 10.1016/j.appet.2010.05.090  1
2010 Schneier FR, Belzer KD, Kishon R, Amsel L, Simpson HB. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study. The Journal of Nervous and Mental Disease. 198: 458-61. PMID 20531128 DOI: 10.1097/NMD.0b013e3181da4d77  1
2010 Maher MJ, Huppert JD, Chen H, Duan N, Foa EB, Liebowitz MR, Simpson HB. Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder. Psychological Medicine. 40: 2013-23. PMID 20416137 DOI: 10.1017/S0033291710000620  1
2010 Blanco C, Alegría AA, Petry NM, Grant JE, Simpson HB, Liu SM, Grant BF, Hasin DS. Prevalence and correlates of fire-setting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of Clinical Psychiatry. 71: 1218-25. PMID 20361899 DOI: 10.4088/JCP.08m04812gry  1
2010 Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety. 27: 507-27. PMID 20217853 DOI: 10.1002/da.20669  1
2010 Simpson HB, Maher M, Page JR, Gibbons CJ, Franklin ME, Foa EB. Development of a patient adherence scale for exposure and response prevention therapy. Behavior Therapy. 41: 30-7. PMID 20171325 DOI: 10.1016/j.beth.2008.12.002  1
2010 Mantovani A, Simpson HB, Fallon BA, Rossi S, Lisanby SH. Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 217-27. PMID 19691873 DOI: 10.1017/S1461145709990435  1
2010 Simpson HB, Schneier F, Lewis-Fernández R, Neria Y. Conclusion: Gaps in knowledge and future directions Anxiety Disorders: Theory, Research, and Clinical Perspectives. 356-361. DOI: 10.1017/CBO9780511777578.033  1
2010 Rodriguez CI, Simpson HB. Evidence-based treatment for patients with obsessive–compulsive disorder: Questions and controversies Anxiety Disorders: Theory, Research, and Clinical Perspectives. 249-259. DOI: 10.1017/CBO9780511777578.024  1
2010 Pinto A, Grados MA, Simpson HB. Challenges in OCD research: Overcoming heterogeneity Anxiety Disorders: Theory, Research, and Clinical Perspectives. 69-79. DOI: 10.1017/CBO9780511777578.009  1
2010 Simpson HB, Neria Y, Lewis-Fernández R, Schneier F. Introduction: The need for interdisciplinary approaches Anxiety Disorders: Theory, Research, and Clinical Perspectives. 1-5. DOI: 10.1017/CBO9780511777578.003  1
2010 Simpson HB, Neria Y, Lewis-Fernández R, Schneier F. Anxiety disorders: Theory, research, and clinical perspectives Anxiety Disorders: Theory, Research, and Clinical Perspectives. 1-378. DOI: 10.1017/CBO9780511777578  1
2009 Wang L, Simpson HB, Dulawa SC. Assessing the validity of current mouse genetic models of obsessive-compulsive disorder. Behavioural Pharmacology. 20: 119-33. PMID 19339874 DOI: 10.1097/FBP.0b013e32832a80ad  1
2009 Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depression and Anxiety. 26: 39-45. PMID 18800368 DOI: 10.1002/da.20506  1
2008 Blanco C, Grant J, Petry NM, Simpson HB, Alegria A, Liu SM, Hasin D. Prevalence and correlates of shoplifting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The American Journal of Psychiatry. 165: 905-13. PMID 18381900 DOI: 10.1176/appi.ajp.2008.07101660  1
2008 Simpson HB, Zuckoff A, Page JR, Franklin ME, Foa EB. Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial. Cognitive Behaviour Therapy. 37: 38-49. PMID 18365797 DOI: 10.1080/16506070701743252  1
2008 Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. The American Journal of Psychiatry. 165: 621-30. PMID 18316422 DOI: 10.1176/appi.ajp.2007.07091440  1
2008 Simpson HB, Petkova E, Cheng J, Huppert J, Foa E, Liebowitz MR. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research. Journal of Psychiatric Research. 42: 631-8. PMID 17892885 DOI: 10.1016/j.jpsychires.2007.07.012  1
2008 Schneier FR, Martinez D, Abi-Dargham A, Zea-Ponce Y, Simpson HB, Liebowitz MR, Laruelle M. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depression and Anxiety. 25: 1-7. PMID 17252580 DOI: 10.1002/da.20268  1
2007 Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 164: 5-53. PMID 17849776  1
2007 Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depression and Anxiety. 24: 77-84. PMID 16892419 DOI: 10.1002/da.20176  1
2007 Huppert JD, Walther MR, Hajcak G, Yadin E, Foa EB, Simpson HB, Liebowitz MR. The OCI-R: validation of the subscales in a clinical sample. Journal of Anxiety Disorders. 21: 394-406. PMID 16814981 DOI: 10.1016/j.janxdis.2006.05.006  1
2007 Patel SR, Carmody J, Simpson HB. Adapting Mindfulness-based Stress Reduction for the Treatment of Obsessive-compulsive Disorder: A Case Report Cognitive and Behavioral Practice. 14: 375-380. DOI: 10.1016/j.cbpra.2006.08.006  1
2007 Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder work group on obsessive-compulsive disorder American Journal of Psychiatry. 164: 1-53.  1
2006 Blanco C, Olfson M, Stein DJ, Simpson HB, Gameroff MJ, Narrow WH. Treatment of obsessive-compulsive disorder by U.S. psychiatrists. The Journal of Clinical Psychiatry. 67: 946-51. PMID 16848654  1
2006 Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 67: 269-76. PMID 16566623  1
2006 Simpson HB, Rosen W, Huppert JD, Lin SH, Foa EB, Liebowitz MR. Are there reliable neuropsychological deficits in obsessive-compulsive disorder? Journal of Psychiatric Research. 40: 247-57. PMID 15950242 DOI: 10.1016/j.jpsychires.2005.04.004  1
2005 Simpson HB, Franklin ME, Cheng J, Foa EB, Liebowitz MR. Standard criteria for relapse are needed in obsessive-compulsive disorder. Depression and Anxiety. 21: 1-8. PMID 15806597 DOI: 10.1002/da.20052  1
2005 Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. The American Journal of Psychiatry. 162: 151-61. PMID 15625214 DOI: 10.1176/appi.ajp.162.1.151  1
2005 Franklin ME, Simpson HB. Combining pharmacotherapy and exposure plus ritual prevention for obsessive compulsive disorder: Research findings and clinical applications Journal of Cognitive Psychotherapy. 19: 317-330. DOI: 10.1891/jcop.2005.19.4.317  1
2004 Huppert JD, Schultz LT, Foa EB, Barlow DH, Davidson JR, Gorman JM, Shear MK, Simpson HB, Woods SW. Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. The American Journal of Psychiatry. 161: 1485-7. PMID 15285978 DOI: 10.1176/appi.ajp.161.8.1485  1
2004 Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R. Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depression and Anxiety. 19: 225-33. PMID 15274171 DOI: 10.1002/da.20003  1
2003 Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A, Liebowitz MR, Laruelle M. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biological Psychiatry. 54: 1414-21. PMID 14675806 DOI: 10.1016/S0006-3223(03)00544-4  1
2003 Schneier FR, Blanco C, Campeas R, Lewis-Fernandez R, Lin SH, Marshall R, Schmidt AB, Sanchez-Lacay JA, Simpson HB, Liebowitz MR. Citalopram treatment of social anxiety disorder with comorbid major depression. Depression and Anxiety. 17: 191-6. PMID 12820174 DOI: 10.1002/da.10112  1
2002 Vicario DS, Raksin JN, Naqvi NH, Thande N, Simpson HB. The relationship between perception and production in songbird vocal imitation: what learned calls can teach us. Journal of Comparative Physiology. a, Neuroethology, Sensory, Neural, and Behavioral Physiology. 188: 897-908. PMID 12471489 DOI: 10.1007/s00359-002-0354-2  1
2002 Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 1431-8. PMID 12447029 DOI: 10.1097/00004583-200212000-00014  1
2001 McWilliams LA, Cox BJ, Enns MW. Trauma and depersonalization during panic attacks. The American Journal of Psychiatry. 158: 656-7. PMID 11282717 DOI: 10.1176/appi.ajp.158.4.656  1
2000 Marshall RD, Schneier FR, Lin SH, Simpson HB, Vermes D, Liebowitz M. Childhood trauma and dissociative symptoms in panic disorder. The American Journal of Psychiatry. 157: 451-3. PMID 10698824 DOI: 10.1176/appi.ajp.157.3.451  1
1999 Simpson HB, Gorfinkle KS, Liebowitz MR. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. The Journal of Clinical Psychiatry. 60: 584-90. PMID 10520976  1
1998 Simpson HB, Schneier FR, Marshall RD, Campeas RB, Vermes D, Silvestre J, Davies S, Liebowitz MR. Low dose selegiline (L-Deprenyl) in social phobia. Depression and Anxiety. 7: 126-9. PMID 9656093 DOI: 10.1002/(SICI)1520-6394(1998)7:3<126::AID-DA5>3.0.CO;2-9  1
1998 Simpson HB, Schneier FR, Campeas RB, Marshall RD, Fallon BA, Davies S, Klein DF, Liebowitz MR. Imipramine in the treatment of social phobia. Journal of Clinical Psychopharmacology. 18: 132-5. PMID 9555598 DOI: 10.1097/00004714-199804000-00005  1
1997 Simpson HB, Hurowitz GI, Liebowitz MR. General principles in the pharmacotherapy of antidepressant-induced rapid cycling: a case series. Journal of Clinical Psychopharmacology. 17: 460-6. PMID 9408808 DOI: 10.1097/00004714-199712000-00004  1
1997 Simpson HB, Nee JC, Endicott J. First-episode major depression. Few sex differences in course. Archives of General Psychiatry. 54: 633-9. PMID 9236547  1
1996 Simpson HB, Liebowitz MR. Antidepressant-induced cycle acceleration in bipolar disorder. The American Journal of Psychiatry. 153: 1239. PMID 8780445  1
1996 Simpson HB, Vicario DS. Male zebra finches can learn male-typical vocalizations from hormone- treated female tutors Animal Behaviour. 52: 1119-1127. DOI: 10.1006/anbe.1996.0259  1
1995 Vicario DS, Simpson HB. Electrical stimulation in forebrain nuclei elicits learned vocal patterns in songbirds. Journal of Neurophysiology. 73: 2602-7. PMID 7666168  1
1991 Simpson HB, Vicario DS. Early estrogen treatment of female zebra finches masculinizes the brain pathway for learned vocalizations. Journal of Neurobiology. 22: 777-93. PMID 1765783 DOI: 10.1002/neu.480220711  1
1991 Simpson HB, Vicario DS. Early estrogen treatment alone causes female zebra finches to produce learned, male-like vocalizations. Journal of Neurobiology. 22: 755-76. PMID 1765782 DOI: 10.1002/neu.480220710  1
1990 Simpson HB, Vicario DS. Brain pathways for learned and unlearned vocalizations differ in zebra finches. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1541-56. PMID 2332796  1
1986 Simpson HB, Tobias ML, Kelley DB. Origin and identification of fibers in the cranial nerve IX-X complex of Xenopus laevis: Lucifer Yellow backfills in vitro. The Journal of Comparative Neurology. 244: 430-44. PMID 3958236 DOI: 10.1002/cne.902440403  1
Show low-probability matches.